Over the past few years there is a dramatic change in the complexity of Clinical Trials and Monitoring of Clinical Trials is still one of the most cardinal approaches in the Pharma Industry. But on-site monitoring can be a quite costly option for its effectiveness, creating a demand in the sector for a more efficient process – Risk-Based Monitoring. Embracing a real-time overview of data in combination with excellently-established risk detection and mitigation tactics, results in the most efficacious technique for handling a clinical programme.
Who is this training suitable for?
Quality Assurance specialists
Clinical research specialists
Regulatory Affairs professionals
Full Training Content
Overview of risk management in clinical trials
Background to RBM – why a change is needed
Types of monitoring plan
Risk based monitoring in action
Current best practices
Corporate Solutions and Certification
This training is also available as a corporate solution, which includes an administrative panel through which an appointed person, such as the HR Manager, can select who does the training when, as well as monitoring tools and access to statistics. The PRA training is also offered in the form of face-to-face training, where experts from our International Network of Trainers come to you; additional content customisations are available upon request.